Paxlovid is an oral antiviral drug used to reduce the risk of hospitalization or death from COVID-19. Paxlovid is authorized for use early in the course of a COVID infection—when illness is mild or moderate—in people aged 12 and older who are at high risk for severe COVID-19. Treatment must begin with 5 days of onset of illness. In clinical trials, Paxlovid reduced the risk of hospitalization or death by 89%. People who are considered high risk include older adults and those with underlying medical conditions such as cancer, diabetes, or heart disease.
Currently, Paxlovid is not available over the counter, but it is available at no cost when prescribed by a healthcare provider or pharmacist.
Updated July 22, 2022